Agendia And Agilent Announce Plans To Jointly Develop New Diagnostic Tests, Extend Supply Agreement

AMSTERDAM, Netherlands and SANTA CLARA, California, April 22 /PRNewswire/ -- Agendia BV, a world leader in the rapidly evolving field of molecular diagnostics, and Agilent Technologies, Inc. (NYSE: A), today announced terms under which they intend to collaborate to develop new in-vitro diagnostic tests.

Related Keywords

Amsterdam ,Noord Holland ,Netherlands ,California ,United States ,Yvonne Linney ,Agendia Mammaprint ,Kelly Connor ,Stuart Matlow ,Agilent Agendia ,Drug Administration ,Agilent Technologies ,Agilent Technologies Inc ,Bernhard Sixt ,United States Food ,Unknown Primary ,For Agendia ,For Agilent ,Bernhard Sixt Stuart Matlow ,Vice President ,Ogilvy Public Relations Worldwide ,Cancer Research ,